Crinetics Pharmaceuticals (CRNX) Return on Sales (2017 - 2025)
Historic Return on Sales for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to 909.73%.
- Crinetics Pharmaceuticals' Return on Sales fell 6469600.0% to 909.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 275.37%, marking a year-over-year decrease of 126000.0%. This contributed to the annual value of 286.26% for FY2024, which is 2341300.0% down from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Return on Sales stood at 909.73% for Q3 2025, which was down 6469600.0% from 112.18% recorded in Q2 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' Return on Sales peaked at 10.74% during Q1 2022, and registered a low of 909.73% during Q3 2025.
- For the 5-year period, Crinetics Pharmaceuticals' Return on Sales averaged around 168.94%, with its median value being 99.93% (2022).
- As far as peak fluctuations go, Crinetics Pharmaceuticals' Return on Sales surged by 10131400bps in 2021, and later tumbled by -6469600bps in 2025.
- Crinetics Pharmaceuticals' Return on Sales (Quarter) stood at 28.58% in 2021, then crashed by -125bps to 64.39% in 2022, then grew by 19bps to 52.12% in 2023, then plummeted by -449bps to 286.29% in 2024, then crashed by -218bps to 909.73% in 2025.
- Its last three reported values are 909.73% in Q3 2025, 112.18% for Q2 2025, and 267.51% during Q1 2025.